Cita APA

Kas, B., Talbot, H., Ferrara, R., Richard, C., Lamarque, J., Pitre-Champagnat, S., . . . Caramella, C. (2020). Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer. JAMA Oncol.

Chicago Style Citation

Kas, Baptiste, et al. "Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer." JAMA Oncol 2020.

Cita MLA

Kas, Baptiste, et al. "Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer." JAMA Oncol 2020.